Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Korean media: South Korean President Yin Xiyue tried to appoint a new defense minister. The East Asia Daily did not explain that the source reported that South Korean President Yin Xiyue tried to appoint a new defense minister, which indicated that Yin Xiyue might resume his job, although he said last week that he would let the ruling party decide how to stabilize future state affairs and his term of office. After making a public speech on Thursday, Yin Xiyue approved the 42 agendas adopted at this week's cabinet meeting. This shows that Yin Xiyue may exercise the presidential power immediately after he hinted in his speech that he had no intention of stepping down.Rio Tinto will invest $2.5 billion to develop a new lithium mine in Argentina, and Rio Tinto Group plans to invest $2.5 billion to develop a new lithium mine in Argentina, which is a victory for Argentine President Javier Millay, who is trying to loosen the control of the economy and attract foreign investment. The British company said in an announcement on Thursday that it plans to build a processing plant with an annual output of 60,000 tons of lithium carbonate in Rincon mine. Subject to permission, the construction of the facility will begin in the middle of next year.
A spokesman for UnitedHealth Group said that the mother of Mangione, a suspect accused of shooting a company executive, also had no insurance for UnitedHealth.Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.[In November, the global sales of pure electric and plug-in hybrid vehicles exceeded 1.8 million, with China accounting for 70%. According to the data released by market research company Rho Motion on Friday, the global sales of pure electric and plug-in hybrid vehicles increased for the seventh consecutive month in November, with a year-on-year increase of 32.3%, reaching 1.83 million, the third consecutive month reaching a record high. Among them, the sales of pure electric and plug-in hybrid vehicles in China market increased by 50%, reaching 1.27 million vehicles, accounting for nearly 70% of the total global sales.
The 22nd meeting of the expert working group of the Shanghai Defense Ministers' Association was held in Beijing. On the morning of December 13th, Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, released news on the recent military-related issues. Wu Qian: On December 12th, China's Ministry of National Defense held the 22nd meeting of the expert working group of the meeting of defense ministers of SCO member states in Beijing. More than 30 representatives from SCO member states and the Secretariat attended the meeting, and all parties had an in-depth exchange of views on strengthening pragmatic cooperation in the field of defense and security and promoting the construction of cooperation mechanisms.The leading enterprises in the quantum science and technology sector are competing for layout. Recently, the quantum science and technology sector has been active. Since September 24, the concept index of the straight flush quantum science and technology has risen by more than 60%, and the stock prices of many stocks have doubled. Among A-share listed companies, many companies including China Mobile, China Telecom, Guo Dun Quantum, Hexin Instrument, Guoxin Technology and Geer Software have already laid out in the field of quantum technology. In terms of future market potential, ICVTA&K, a scientific and technological consulting organization, predicts that in 2023, the overall market size of the global quantum industry may reach 7.24 billion US dollars. However, the current quantum technology industry is still in the stage of research and development and industrial exploration. Taking quantum computing as an example, Guo Dun Quantum said in a survey conducted by an organization on November 15th that quantum computers have only achieved quantum superiority in some specific problems at present, and it is estimated that it will take about 5 to 10 years to surpass classical computing power in practical and valuable problems in the future. (Economic Information Daily)Pfizer announced an increase in its quarterly dividend, and American pharmaceutical giant Pfizer said on Thursday that it would increase its quarterly dividend by 2.4%, from 42 cents to 43 cents per share. The new dividend is equivalent to $1.72 per year, which means that the annual yield is about 6.8%. Albert Bourla, CEO of Pfizer, said that the dividend increase highlighted the company's strong financial performance, execution and commitment to return capital to shareholders.